Study guide
Essential Hypertension & Hypertensive Urgency/Emergency Management
AANPCB Adult-Gerontology Primary Care Nurse Practitioner A-GNP
Track your progress as you read
Finished sections get a check mark.
1 Exam Structure, APRN Foundations & Geriatric Assessment
A-GNP Exam Logistics, Blueprint & Scoring Structure APRN Scope of Practice, Consensus Model & Interprofessional Collaboration Comprehensive Health History & Subjective Assessment Across Adult Lifespan Comprehensive Physical Examination & Clinical Assessment Skills
2 Health Assessment, Diagnostic Reasoning & Clinical Procedures
Diagnostic Reasoning, Test Interpretation & Clinical Decision-Making Screening Guidelines & Evidence-Based Health Promotion (USPSTF) Comprehensive Geriatric Assessment (CGA), Frailty & Function In-Office Clinical Procedures, ECG Interpretation & Minor Surgical Skills
3 Cardiovascular & Peripheral Vascular Disorders
Essential Hypertension & Hypertensive Urgency/Emergency Management Coronary Artery Disease, Acute Coronary Syndromes & Post-MI Care Heart Failure (HFrEF & HFpEF) Diagnosis, Staging & 4-Pillar GDMT Arrhythmias (Atrial Fibrillation), Valvular Heart Disease & PAD
4 Respiratory, HEENT & Dermatological Disorders
Asthma Management across the Adult Lifespan (GINA Guidelines) Chronic Obstructive Pulmonary Disease (COPD) Staging & Management (GOLD Guidelines) Community-Acquired Pneumonia & Lower Respiratory Tract Infections Common HEENT Disorders: Otitis, Sinusitis, Pharyngitis, Glaucoma & Macular Degeneration
5 Endocrine, Metabolic & Renal/Genitourinary Disorders
Type 2 Diabetes Mellitus Management Thyroid Disorders: Hypothyroidism, Hyperthyroidism & Subclinical Disease Chronic Kidney Disease (CKD) Staging & Diabetic/Hypertensive Nephropathy Genitourinary Disorders: BPH, Urinary Incontinence, UTIs & Prostatitis
6 Gastrointestinal, Hematologic & Immunologic Disorders
Upper Gastrointestinal Disorders: Dyspepsia, GERD, PUD & H. pylori Lower Gastrointestinal Disorders: IBS, IBD, Diverticulitis & Colorectal Screening Liver, Biliary & Pancreatic Disorders: NAFLD/MASLD, Cirrhosis & Cholecystitis Hematologic & Immunologic Disorders: Anemias, Anticoagulation & Immunizations
7 Neurological, Cognitive & Psychiatric Disorders
Cognitive Assessment: Delirium, Dementia & Mild Cognitive Impairment Neurological Disorders: Stroke, TIA, Parkinson's Disease & Headache Syndromes Major Depressive Disorder & Anxiety Disorders in Adults & Older Adults Sleep Disorders, Insomnia & Restless Legs Syndrome
8 Geriatric Syndromes, Polypharmacy & Deprescribing
The Beers Criteria & STOPP/START Criteria for Potentially Inappropriate Medication Use Polypharmacy Management, Pharmacokinetics/Pharmacodynamics in Aging & Deprescribing Protocols Fall Risk Assessment (CDC STEADI), Gait/Balance & Mobility Impairments Pressure Injury Prevention/Staging, Urinary/Fecal Incontinence & Frailty Assessment
9 APRN Professional Practice, Ethics, Quality & Healthcare Policy
Musculoskeletal Disorders: Osteoarthritis, Osteoporosis, Gout & Back Pain Dermatological Disorders: Lesions, Skin Cancers, Infections & Rash Evaluation Palliative Care, Advance Care Planning, Pain Management & End-of-Life APRN Professional Practice, Quality Improvement, Ethics & Healthcare Policy
Essential Hypertension & Hypertensive Urgency/Emergency Management
Key Takeaways Explain This Topic AI
Stage 1 HTN is defined as SBP 130-139 mmHg or DBP 80-89 mmHg, while Stage 2 HTN is SBP >=140 mmHg or DBP >=90 mmHg according to the ACC/AHA guidelines.
First-line antihypertensive classes for uncomplicated non-Black patients include thiazide-like diuretics (chlorthalidone), CCBs, and ACE inhibitors or ARBs, whereas Black patients without CKD benefit most from CCBs or thiazides as initial therapy.
ACE inhibitors or ARBs are mandatory first-line therapy for patients with hypertension and chronic kidney disease with albuminuria or diabetes with microalbuminuria.
Hypertensive urgency is characterized by SBP >180 mmHg or DBP >120 mmHg without end-organ damage and is managed with oral agents over 24 to 48 hours, whereas hypertensive emergency involves acute target organ damage requiring immediate IV titratable antihypertensives in an ICU setting.
In older adults, screen routinely for orthostatic hypotension (drop in SBP >=20 mmHg or DBP >=10 mmHg within 3 minutes of standing) and avoid high-risk medications listed on the Beers Criteria such as alpha-1 blockers and central alpha-2 agonists.
Last updated: July 2026
- Essential Hypertension & Hypertensive Urgency/Emergency Management
- Pathophysiology and Hemodynamic Determinants
Hypertension (HTN) is the primary modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, stroke, and chronic kidney disease (CKD). Blood pressure is determined by the relationship: Blood Pressure = Cardiac Output (CO) x Systemic Vascular Resistance (SVR). In young adults, hypertension is frequently driven by increased cardiac output associated with hyperdynamic sympathetic tone. In older adults, hypertension is primarily driven by arterial stiffening, loss of vascular elasticity, and structural vascular remodeling, resulting in elevated SVR and isolated systolic hypertension.
The renin-angiotensin-aldosterone system (RAAS) regulates long-term blood pressure and renal hemodynamics. Angiotensinogen is converted by renin (released by juxtaglomerular cells in response to reduced renal perfusion) into angiotensin I, which is converted to angiotensin II by angiotensin-converting enzyme (ACE) in the pulmonary endothelium. Angiotensin II causes direct arterial vasoconstriction and stimulates adrenal aldosterone secretion, promoting renal sodium and water reabsorption while enhancing potassium excretion. Overactivation of RAAS causes persistent arterial vasoconstriction, volume expansion, and target organ damage.
ACC/AHA Blood Pressure Classification and Measurement Standards
Accurate blood pressure measurement requires standardized in-office protocols. Patients must sit quietly for 5 minutes before measurement, with back supported and feet flat on the floor. The arm must be supported at heart level; taking BP on an unsupported arm falsely elevates systolic pressure by 2-10 mmHg. The cuff bladder must encircle at least 80% of upper arm circumference. Patients should avoid caffeine, exercise, and smoking for 30 minutes prior. Diagnosing hypertension requires an average of two or more properly measured readings over separate clinical encounters.
Ambulatory Blood Pressure Monitoring (ABPM) or Home Blood Pressure Monitoring (HBPM) is recommended to confirm diagnosis and rule out white-coat hypertension (elevated in-office BP but normal out-of-office BP) or masked hypertension (normal in-office BP but elevated out-of-office BP).
- Blood Pressure Category Systolic BP (mmHg) Diastolic BP (mmHg)
- Normal < 120 and < 80
- Elevated 120 - 129 and < 80
- Stage 1 Hypertension 130 - 139 or 80 - 89
- Stage 2 Hypertension >= 140 or >= 90
- First-Line Pharmacotherapy and Demographic Preferences
Target blood pressure for most adults, including those with established ASCVD, diabetes, CKD, or 10-year ASCVD risk >=10%, is <130/80 mmHg . Lifestyle modifications (DASH diet, sodium restriction <1,500-2,300 mg/day, weight loss, exercise 150 min/week, limiting alcohol) are indicated for all patients.
First-line antihypertensive agents for uncomplicated hypertension belong to three major classes:
Thiazide/Thiazide-like Diuretics: Chlorthalidone (12.5-25 mg daily) and indapamide are preferred over Hydrochlorothiazide (HCTZ) due to longer half-lives (40-60 hours vs. 6-12 hours) and superior reduction in ASCVD events. Adverse effects include hyponatremia, hypokalemia, hyperuricemia (gout), and hyperglycemia.
Calcium Channel Blockers (CCBs): Dihydropyridine CCBs (amlodipine 5-10 mg daily, nifedipine ER) induce arteriolar smooth muscle relaxation and vasodilation. Dose-dependent peripheral edema is common; combining a CCB with an ACE inhibitor or ARB reduces edema. Non-dihydropyridines (diltiazem, verapamil) exert negative inotropic effects and are avoided in HFrEF.
ACE Inhibitors and ARBs: ACE inhibitors (lisinopril, enalapril) prevent conversion of angiotensin I to II, while ARBs (losartan, valsartan) block AT1 receptors. Both classes reduce SVR and provide renal microvascular protection. ACE inhibitor side effects include dry cough (bradykinin accumulation) and angioedema. ARBs do not affect bradykinin and are preferred if cough occurs. Both cause hyperkalemia and modest serum creatinine elevations (up to 30% rise is acceptable). Both are strictly contraindicated in pregnancy due to fetal toxicity.
Demographic Preferences: In Black adults without chronic kidney disease, initial therapy should consist of a dihydropyridine CCB or thiazide diuretic. Black patients demonstrate greater blood pressure reduction and stroke prevention with CCBs and thiazides compared to ACE inhibitors or ARBs as monotherapy.
Compelling Indications and Secondary Hypertension
Compelling comorbid conditions dictate drug selection regardless of race:
CKD with Albuminuria: In patients with CKD (eGFR <60 mL/min/1.73 m²) or diabetes with persistent albuminuria (UACR >=30 mg/g), an ACE inhibitor or ARB is mandatory first-line therapy to reduce intraglomerular pressure and slow kidney disease progression.
Post-MI and HFrEF: Patients with prior MI or HFrEF require an ACE inhibitor/ARB (or ARNI) plus an evidence-based beta-blocker (carvedilol, metoprolol succinate, bisoprolol).
Stroke History: A thiazide diuretic plus ACE inhibitor is recommended post-stroke.
Secondary hypertension accounts for 5-10% of cases and should be evaluated in abrupt onset, age <30 or >55, or resistant cases:
Renal Artery Stenosis: Suspect in older adults with progressive vascular disease or young females with fibromuscular dysplasia (abdominal bruit or acute >30% rise in creatinine on ACEi/ARB).
Primary Aldosteronism: Suggested by resistant HTN with unprovoked hypokalemia (plasma aldosterone-to-renin ratio ARR >20).
Obstructive Sleep Apnea (OSA): Common in obese patients with snoring, fatigue, and resistant HTN.
Resistant Hypertension is defined as BP above target despite adherence to 3 optimal-dose agents of different classes, including a diuretic. Management includes ruling out pseudo-resistance, stopping interfering agents (NSAIDs, decongestants), and adding Spironolactone (12.5-25 mg daily) as fourth-line agent (provided K+ <5.0 mEq/L and eGFR >=30 mL/min/1.73 m²).
Hypertensive Crises: Urgency vs. Emergency Management
Hypertensive crisis is defined as severe acute BP elevation, typically SBP >180 mmHg and/or DBP >120 mmHg.
Hypertensive Urgency: SBP >180 mmHg and/or DBP >120 mmHg WITHOUT acute target organ damage. Managed with oral antihypertensives (labetalol, captopril, clonidine) over 24 to 48 hours in outpatient settings. Rapid BP lowering must be avoided to prevent ischemic stroke or MI.
Hypertensive Emergency: SBP >180 mmHg and/or DBP >120 mmHg WITH acute target organ damage (encephalopathy, stroke, acute coronary syndrome, acute pulmonary edema, aortic dissection, acute renal failure, papilledema). Requires immediate ICU admission and continuous IV infusions (nicardipine, clevidipine, labetalol, esmolol).
BP Lowering Goals in Emergency: Reduce SBP by maximum 25% within 1st hour ; then to 160/100 mmHg over 2 to 6 hours, cautiously normalizing over 24 to 48 hours. Clinical Exceptions:
Aortic Dissection: Rapidly lower SBP to <120 mmHg within 20 minutes (with IV beta-blockers targeting HR <60 bpm).
Acute Ischemic Stroke: Do not lower BP unless SBP >220 mmHg or DBP >120 mmHg, UNLESS eligible for thrombolysis (target <185/110 mmHg before tPA).
Geriatric Considerations
In older adults, screen routinely for orthostatic hypotension (drop in SBP >=20 mmHg or DBP >=10 mmHg within 3 minutes of standing). According to the 2023 AGS Beers Criteria, central alpha-2 agonists (clonidine) and alpha-1 blockers (doxazosin, terazosin) should be avoided for routine HTN management due to high risks of CNS depression, severe orthostatic hypotension, and falls.